Parkman Healthcare Partners’s Insmed INSM Stock Holding History

Parkman Healthcare Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-37,901	Closed	-$2.89M	–	92
2025 Q1	$2.89M	Buy	37,901 +2,233	+6%	+$171K	0.34%	67
2024 Q4	$2.46M	Buy	35,668 +235	+0.7%	+$16.9K	0.33%	65
2024 Q3	$2.59M	Sell	35,433 -44,838	-56%	-$3.31M	0.33%	68
2024 Q2	$5.38M	Sell	80,271 -12,761	-14%	-$495K	0.72%	48
2024 Q1	$2.52M	Sell	93,032 -57,784	-38%	-$1.62M	0.31%	77
2023 Q4	$4.67M	Buy	150,816 +25,816	+21%	+$669K	0.66%	49
2023 Q3	$3.16M	Buy	+125,000	New	+$2.86M	0.58%	49

Other funds holding INSM

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Parkman Healthcare Partners's INSM Position: Q2 2025 in Review

Parkman Healthcare Partners sold out of Insmed (INSM) in Q2 2025, closing a stake of 37,901 shares — an estimated $2.89M sold.

Parkman Healthcare Partners first reported a position in INSM in Q3 2023 and held it in 7 quarters. The position peaked at $5.38M in Q2 2024. 516 funds tracked by Wall St. Rank hold INSM as of Q2 2025.

Parkman Healthcare Partners reported no remaining Insmed position as of Q2 2025 after selling out during the quarter.
Parkman Healthcare Partners sold 37,901 Insmed shares in Q2 2025, an estimated $2.89M.
Parkman Healthcare Partners first reported a position in Insmed in Q3 2023 and held it in 7 quarters.
Parkman Healthcare Partners's Insmed position peaked at $5.38M in Q2 2024.
516 funds tracked by Wall St. Rank held Insmed as of Q2 2025.

Based on Parkman Healthcare Partners's 13F filing for Q2 2025, filed 14 Aug 2025.